Skip to content. | Skip to navigation

Personal tools
Log in
You are here: Home Know-who Know-how Directory From A to Z Solvay Pharmaceuticals

Solvay Pharmaceuticals

Business focus: We are an R&D based pharmaceutical company. It is particularly well placed in its selected therapeutic fields; neuroscience, cardiometabolics, flu vaccines, pancreatic enzymes, gastroenterology and women’s and men’s health.

Solvay

Solvay Pharmaceuticals
C.J. van Houtenlaan 36
1381 CP Weesp
Website Solvay Pharmaceuticals
E-mail Solvay pharmaceuticals
T +31 (0)294 47 70 00

Employees in Amsterdam: 1200
Employees in R&D: 500
Year of foundation: 1863


Company Profile

Solvay Pharmaceuticals is part of the Solvay Group, together with two other sectors: Chemicals and Plastics. Building on its scientific, technical and commercial expertise, Solvay Pharmaceuticals responsibly provides innovative products and services related to human health to create ever-increasing value to its patients, shareholders and employees

Science and Technologies or Services

Solvay Pharmaceuticals is a research driven group of companies that constitute the global pharmaceutical business of the Solvay Group. The company seeks to fulfill carefully selected, unmet medical needs in the focus areas of neuroscience, cardio-metabolic, influenza vaccines and pancreatic enzymes. We aim for marketing excellence in gastroenterology and  men’s and women’s health

Alliances

With its excellent position and reputation in Europe and its growing presence in the US and the Far East, Solvay Pharmaceuticals considers itself as a preferred partner for alliances, licensing products, or for assistance in development, regulatory and marketing matters. We have alliances with highly skilled partners like Wyeth,  Lundbeck, Bristol Myers Squibb and the CRO Quintiles. In addition we are an active member of the Top Institute Pharma and IMI.
We also co operate with most Dutch Universities.

Keywords

  • Neuroscience
  • Influenza
  • Psychiatry
  • Neurology
  • Parkinson
  • Alzheimer
  • Cardiovascular
  • Metabolic syndrome

Document Actions

Find your life sciences partner in the Amsterdam BioMed Cluster

Find your life sciences partner in the Amsterdam BioMed Cluster

Column

Penny-wise!

Synaps bij column Arjen Brussaard, foto CNCR.nl

By Arjen Brussaard

Recently the topsector plan Life Sciences & Health was published and presented to Minister Verhagen, of the so-called ELI Ministry. The document is an amazing compressed 60-pager, based on months of hard work by the group of experts chaired by Roel Fonville, and summarizes the conclusions after dozens of 1-to-1 meetings, five regional group sessions with dozens of opinion leaders and after having received over 170 (!) memo's, white papers and letters of intent.
More...